DEA to Classify Liquid, Synthetic THC as a Schedule II Controlled Substance

NORML | March 30, 2017

WASHINGTON, DC — Officials from the US Drug Enforcement Administration (DEA) have recommended that Syndros, a liquid form of synthetic THC, be classified as a Schedule II controlled substance under federal law.

Food and Drug Administration (FDA) officials determined last year that the drug formulation is safe and effective for use by patients with cancer and AIDS.

Two other synthetic forms of THC, dronabinol and nabilone, are also FDA approved. Dronabinol (aka Marinol) is a…